MedTrace Logo

Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota

NCT02040922 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2017-05-04

No results posted yet for this study

Summary

The principal research objective is to determine the impact of antibiotic use on the risk of developing long term bowel symptoms after infection with the germ Campylobacter.

Conditions

  • Campylobacter Infections
  • Irritable Bowel Syndrome

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    collaborator OTHER

  • Department of Health, United Kingdom

    collaborator OTHER_GOV

  • King's College London

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Robin C Spiller, MSc MD FRCP · University of Nottingham

  • Giles AD Major, BM BCh MRCP · University of Nottingham

  • Mathew Diggle, MSc PhD · Nottingham University Hospitals NHS Trust

  • Richard Puleston, MBBS PhD · University of Nottingham

  • Miranda Lomer, PhD RD · King's College London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2017-02-28
Completion
2017-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02040922 on ClinicalTrials.gov